Indication
Fertility Preservation
5 clinical trials
10 products
2 drugs
Clinical trial
Neoadjuvant Chemotherapy Plus Camrelizumab (NACI Therapy) for Fertility Preservation in FIGO Stage IB1 Cervical CancerStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Product
CamrelizumabDrug
CisplatinProduct
Nab PaclitaxelClinical trial
FSH and LH Versus FSH Alone for Ovarian Stimulation in Non-hormone Sensitive Onco-fertility Patients: an Exploratory Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2029-12-01
Product
LuverisClinical trial
Neoadjuvant Chemotherapy Plus Cadunilizumab Followed by Extrafascial Hysterectomy for FIGO Stage IB2 Cervical Cancer: a Multicenter, Single-arm, Phase 2 Trial.Status: Not yet recruiting, Estimated PCD: 2026-03-01
Drug
CadonilimabProduct
Paclitaxel-albuminClinical trial
PPOS and CFA for Elective Freeze-all Ovarian Stimulation Cycles: a Prospective Cross-over StudyStatus: Not yet recruiting, Estimated PCD: 2025-05-10
Product
Elonva®Product
Puregon®Product
Orgalutran®Product
Gonapeptyl®Product
Cerazette®Clinical trial
Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial CancerStatus: Not yet recruiting, Estimated PCD: 2028-07-01
Product
Medroxyprogesterone Acetate